Author:
Walsh C. J.,Batt J.,Herridge M. S.,Mathur S.,Bader G. D.,Hu P.,Khatri P.,dos Santos C. C.
Abstract
AbstractMuscle diseases share common pathological features suggesting common underlying mechanisms. We hypothesized there is a common set of genes dysregulated across muscle diseases compared to healthy muscle and that these genes correlate with severity of muscle disease. We performed meta-analysis of transcriptional profiles of muscle biopsies from human muscle diseases and healthy controls. Studies obtained from public microarray repositories fulfilling quality criteria were divided into six categories: (i) immobility, (ii) inflammatory myopathies, (iii) intensive care unit (ICU) acquired weakness (ICUAW), (iv) congenital muscle diseases, (v) chronic systemic diseases, (vi) motor neuron disease. Patient cohorts were separated in discovery and validation cohorts retaining roughly equal proportions of samples for the disease categories. To remove bias towards a specific muscle disease category we repeated the meta-analysis five times by removing data sets corresponding to one muscle disease class at a time in a “leave-one-disease-out” analysis. We used 636 muscle tissue samples from 30 independent cohorts to identify a 52 gene signature (36 up-regulated and 16 down-regulated genes). We validated the discriminatory power of this signature in 657 muscle biopsies from 12 additional patient cohorts encompassing five categories of muscle diseases with an area under the receiver operating characteristic curve of 0.91, 83% sensitivity, and 85.3% specificity. The expression score of the gene signature inversely correlated with quadriceps muscle mass (r = −0.50, p-value = 0.011) in ICUAW and shoulder abduction strength (r = −0.77, p-value = 0.014) in amyotrophic lateral sclerosis (ALS). The signature also positively correlated with histologic assessment of muscle atrophy in ALS (r = 0.88, p-value = 1.62 × 10–3) and fibrosis in muscular dystrophy (Jonckheere trend test p-value = 4.45 × 10–9). Our results identify a conserved transcriptional signature associated with clinical and histologic muscle disease severity. Several genes in this conserved signature have not been previously associated with muscle disease severity.
Funder
Canadian Thoracic Society (CTS) Research Committee of the Lung Association (CLA) studentship
Canadian Institutes of Health Research
Physican Services Incorporated Foundation
Canadian Institutes for Health Research
Publisher
Springer Science and Business Media LLC
Reference80 articles.
1. Walsh, C.J. Transcriptional Profiling and Regulation in Survivors of Critical Illness with Muscle Weakness and Meta-analysis across Human Muscle Diseases. TSpace http://hdl.handle.net/1807/97727. (University of Toronto, 2019).
2. Barreiro, E., Sznajder, J. I., Nader, G. A. & Budinger, G. R. Muscle dysfunction in patients with lung diseases: A growing epidemic. Am. J. Respir. Crit. Care Med. 191(6), 616–619 (2015).
3. Abdulai, R. M. et al. Deterioration of limb muscle function during acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 197(4), 433–449 (2018).
4. Riou, M. et al. Skeletal and respiratory muscle dysfunctions in pulmonary arterial hypertension. J. Clin. Med. 9(2), 410 (2020).
5. Puthucheary, Z. A. et al. Rectus femoris cross-sectional area and muscle layer thickness: Comparative markers of muscle wasting and weakness. Am. J. Respir. Crit. Care Med. 195(1), 136–138 (2017).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献